Last updated: September 20, 2021
Sponsor: California Institute of Integral Studies
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Mild Cognitive Impairment
Inflammation
Dementia
Treatment
N/AClinical Study ID
NCT05050812
PFJ001
Ages > 55 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All approved participants must
- Be at least 55 years of age; all genders and ethnicities;
- Have English as their primary language or be able to speak, read, and writeEnglish fluently; As this is a vulnerable population, this investigator must beable to evaluate understanding and cannot reliably do that with someone who isnot fluent in English;
- Have a current diagnosis of mild cognitive impairment due to Alzheimer's diseasemade by a medical doctor;
- Be able to spend at least 6 hours per 24-hour period sleeping or resting on thegrounded mat;
- Be able to legally consent to participating in this study;
- Agree to allow the researcher to come into their home to setup the equipment andadminister the tests;
- Be able to see well enough to use a laptop to complete electronic testing;
- Be alert and oriented X 4 based on initial verbal screening and in-person visits;
- Reside in or around the Greater Austin, Texas, area/Central Texas area;
- Sleep in a dwelling that is grounded.
Exclusion
Exclusion Criteria:
- All approved participants must
- Not have a diagnosis or conversion to AD or any other type of memory disorderbefore or during the study period including but not limited to dementia, Lewybody disease, Creutzfeldt-Jakob disease, Parkinson's disease, Huntington'sdisease, vascular cognitive impairment, frontotemporal dementias, primaryprogressive aphasia, autoimmune encephalopathy, and normal pressurehydrocephalus;
- Not have a diagnosis of stable MCI;
- Not have any prior diagnosis of traumatic brain injury;
- Not have any history of grounding consistently for more than 60 minutes/day inthe past year. This includes natural methods and the use of any groundingdevices;
- Not have any in-the-moment assessment that leads the investigator to believe thatthe participant is not fully aware or does not understand what is being asked ofthem. Again, this is a vulnerable population, and I will exclude or cut anyparticipant who shows signs of confusion;
- Not be taking or have taken in the previous 30 days any of the followingmedications:
- daily anti-inflammatories, prescription or over the counter;
- blood pressure medications (anti-hypertensives);
- blood thinners (anti-coagulants); e. glucose control medications; f. thyroid medications; g. anti-convulsivemedications (no matter the diagnosis); h. any type of monoclonal antibody; i. anytype of immunosuppressive, including steroids; j. any type of immunomodulator.
- Inability to answer the questions in the initial screening interview;
- Inability to follow instructions. A Note About Medications and Grounding: Earthing has been proven to reduce inflammation, thin the blood, lower blood pressure,lower and better regulate glucose levels, and improve thyroid function. While all thosethings are generally sought after, there could be dire consequences if a participant is ona medication to correct any of those conditions, so in the interest of safety, exclusionbased on certain medications is necessary. In that same vein, if any participant must begina medication during the study period, that participant will be disqualified in the interestof safety.
Study Design
Total Participants: 8
Study Start date:
September 01, 2021
Estimated Completion Date:
December 31, 2021